[Prognosis of the clinical course of post-infarction cardiosclerosis on the basis of pyrophosphate-labeled myocardial scintigraphy].
Predictive value of myocardial 99mTc-pyrophosphate scintigraphy was assessed in 122 patients with postinfarction cardiosclerosis. In those cases where clinical and scintigraphic complication risk estimates considered, further evidence was shown to be redundant. Prognosis in patients with positive scintigraphic results and asymptomatic postinfarction cardiosclerosis or first-to-second class stable angina should take into account the size of myocardial pyrophosphate accumulation focus and the pattern of stress-induced changes in blood supply of the sites of myocardial damage. Negative scintigraphic results have no predictive value in those postinfarction cardiosclerosis patients who show clinical signs of heart failure and/or severe coronary insufficiency at the time of investigation.
Vinogradov
A V
AV
Sycheva
I M
IM
Rylova
A K
AK
D000328:Adult; D000368:Aged; D002311:Cardiomyopathy, Dilated / Q000209:etiology*; D011756:Diphosphates; D005260:Female; D006321:Heart / Q000000981:diagnostic imaging*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications* / Q000000981:diagnostic imaging; D011379:Prognosis; D011877:Radionuclide Imaging; D013667:Technetium; D016698:Technetium Tc 99m Pyrophosphate
D011756:Diphosphates; D016698:Technetium Tc 99m Pyrophosphate; D013667:Technetium
Prognozirovanie klinicheskogo techeniia postinfarktnogo kardioskleroza po dannym stsintigrafii miokarda s mechenym pirofosfatom.